Molecular Partners Ag · SIX:MOLN
Montanova Capital, LLC reported a 10.60% stake in Molecular Partners Ag (Schedule 13G)
Event Jun 15, 2021 · Filed May 2, 2025
Montanova Capital, LLC reported a 10.60% stake in Molecular Partners Ag, 4,284,806 shares, as a passive investor on Jun 15, 2021. Filed May 2, 2025 (Schedule 13G).
- Stake
- 10.60%
- Shares
- 4,284,806
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 10.60% | 4,284,806 |
| Averill Master Fund, Ltd. | 10.60% | 4,284,806 |
| Aaron Cowen | 10.60% | 4,284,806 |
Source
Related
- Molecular Partners Ag
- Montanova Capital, LLC
- Molecular Partners Ag shareholders
- SIX significant shareholder notification · UBS Fund Management (Switzerland) AG · Dec 29, 2025
- SIX significant shareholder notification · UBS Fund Management (Switzerland) AG · Dec 19, 2025
- SIX significant shareholder notification · UBS Fund Management (Switzerland) AG · Dec 16, 2025
- SIX significant shareholder notification · UBS Fund Management (Switzerland) AG · Nov 25, 2025
- Schedule 13G · UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC · Jul 17, 2025